TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ORKA

Oruka Therapeutics, Inc.

Healthcare · Biotechnology

84.50$ +1.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Oruka Therapeutics, Inc. (ORKA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,139 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ORKA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
39 38 37 34 414 396 377 357 509 489 504 1,139
39 38 37 34 413 377 352 332 355 344 395 885
38 37 36 33 411 62 84 65 91 47 50 268
38 37 36 33 411 376 349 328 349 337 389 874
1.2 0.8 1.6 1.3 72 14 12 14 22 17 18 25
1.0 0.6 1.6 1.3 18 13 12 12 21 15 17 23
0.1 0.1 0.0 0.0 0.1 0.2 0.3 0.7 0.4 0.6 0.7 0.7
– – 0.5 0.6 8.5 3.5 3.5 4.7 2.2 4.2 3.7 8.0
– – 25 – – – – – – – – –
38 37 35 33 342 382 365 344 487 472 487 1,115
-188 -189 -191 -193 -58 -84 -105 -129 -160 -189 -221 -262
14 14 15 15 15 17 42 42 44 54 55 63

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?